Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1980 1
1995 2
1999 1
2001 2
2002 2
2003 1
2004 2
2005 1
2006 4
2007 4
2008 5
2009 6
2010 2
2011 9
2012 4
2013 4
2014 4
2015 5
2016 4
2017 3
2018 5
2019 4
2020 1
2021 1
2023 3
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
A phase 1 study of regorafenib and sildenafil in adults with advanced solid tumors.
Poklepovic AS, Gordon SW, Kothadia S, McGuire WP, Thacker LR, Deng X, Tombes MB, Shrader E, Hudson D, Bandyopadhyay D, Ryan AA, Kmieciak M, Smith S, Dent P. Poklepovic AS, et al. Among authors: kmieciak m. Anticancer Drugs. 2024 Jun 1;35(5):450-458. doi: 10.1097/CAD.0000000000001584. Epub 2024 Mar 8. Anticancer Drugs. 2024. PMID: 38452059 Free PMC article. Clinical Trial.
Tumor immunoediting and immunosculpting pathways to cancer progression.
Reiman JM, Kmieciak M, Manjili MH, Knutson KL. Reiman JM, et al. Among authors: kmieciak m. Semin Cancer Biol. 2007 Aug;17(4):275-87. doi: 10.1016/j.semcancer.2007.06.009. Epub 2007 Jun 26. Semin Cancer Biol. 2007. PMID: 17662614 Free PMC article. Review.
Phase 1 study of belinostat and adavosertib in patients with relapsed or refractory myeloid malignancies.
Shafer D, Kagan AB, Rudek MA, Kmieciak M, Tombes MB, Shrader E, Bandyopadhyay D, Hudson D, Sankala H, Weir C, Lancet JE, Grant S. Shafer D, et al. Among authors: kmieciak m. Cancer Chemother Pharmacol. 2023 Mar;91(3):281-290. doi: 10.1007/s00280-023-04511-0. Epub 2023 Mar 2. Cancer Chemother Pharmacol. 2023. PMID: 36864346 Free PMC article. Clinical Trial.
Phase 1 study of belinostat (PXD-101) and bortezomib (Velcade, PS-341) in patients with relapsed or refractory acute leukemia and myelodysplastic syndrome.
Holkova B, Shafer D, Yazbeck V, Dave S, Bose P, Tombes MB, Shrader E, Wan W, Bandyopadhyay D, Weir C, Collins EB, Garnett A, Kmieciak M, Roberts JD, Garcia-Manero G, Grant S. Holkova B, et al. Among authors: kmieciak m. Leuk Lymphoma. 2021 May;62(5):1187-1194. doi: 10.1080/10428194.2020.1861270. Epub 2020 Dec 28. Leuk Lymphoma. 2021. PMID: 33356689 Free PMC article. Clinical Trial.
Phase I Study of Sorafenib and Vorinostat in Advanced Hepatocellular Carcinoma.
Gordon SW, McGuire WP 3rd, Shafer DA, Sterling RK, Lee HM, Matherly SC, Roberts JD, Bose P, Tombes MB, Shrader EE, Ryan AA, Kmieciak M, Nguyen T, Deng X, Bandyopadhyay D, Dent P, Poklepovic AS. Gordon SW, et al. Among authors: kmieciak m. Am J Clin Oncol. 2019 Aug;42(8):649-654. doi: 10.1097/COC.0000000000000567. Am J Clin Oncol. 2019. PMID: 31305287 Clinical Trial.
71 results